23E1 Stock Chart & Stats
€16.04
--
Market closed
€16.04
--
Day’s Range― - ―
52-Week Range€3.28 - €25.20
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
€2.51B
Enterprise Value€41.92
Total Cash (Recent Filing)€3.99M
Total Debt (Recent Filing)€4.32M
Price to Earnings (P/E)―
Beta2.18
Next Earnings
Oct 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.39
Shares Outstanding145,637,450
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)2.32
Price to Sales (P/S)1.64
P/FCF Ratio-1.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€28.47Price Target Upside77.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.09
Revenue Forecast (FY)€158.36M
Bulls Say, Bears Say
Bulls Say
Financial ResultsReported revenues above consensus and a smaller-than-expected net loss per share point to improving financial performance and could boost investor confidence.
M&AProposed merger with Applied Digital Cloud could provide Ekso Bionics with additional capital and cloud resources to stabilize operations and accelerate product development.
Revenue MomentumSequential recovery in sales and improving gross margins suggest that earlier order delays were idiosyncratic and may support renewed revenue momentum.
Bears Say
Asset Sale RiskIntent to pursue sale or divestiture of the legacy MedTech business could reduce recurring medical revenues and introduce execution risk during any transaction process.
Corporate UncertaintyAnnounced strategic review and potential transactions create uncertainty about future direction and could weigh on the stock until strategic outcomes are clarified.
Strategy ChangeMove away from commercializing exoskeletons toward other priorities undermines clarity on the company's core market strategy and may concern shareholders focused on the original technology opportunity.
ChronoScale News
23E1 FAQ
What was ChronoScale’s price range in the past 12 months?
ChronoScale lowest stock price was €3.28 and its highest was €25.20 in the past 12 months.
What is ChronoScale’s market cap?
ChronoScale’s market cap is €2.51B.
When is ChronoScale’s upcoming earnings report date?
ChronoScale’s upcoming earnings report date is Oct 29, 2026 which is in 26 days.
How were ChronoScale’s earnings last quarter?
ChronoScale released its earnings results on Apr 23, 2026. The company reported -€1.77 earnings per share for the quarter, missing the consensus estimate of -€0.028 by -€1.742.
Is ChronoScale overvalued?
According to Wall Street analysts ChronoScale’s price is currently Undervalued.
Does ChronoScale pay dividends?
ChronoScale does not currently pay dividends.
What is ChronoScale’s EPS estimate?
ChronoScale’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ChronoScale have?
ChronoScale has 145,637,450 shares outstanding.
What happened to ChronoScale’s price movement after its last earnings report?
ChronoScale reported an EPS of -€1.77 in its last earnings report, missing expectations of -€0.028. Following the earnings report the stock price went up 2.609%.
Which hedge fund is a major shareholder of ChronoScale?
Currently, no hedge funds are holding shares in DE:23E1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ChronoScale Stock Smart Score
Learn more about TipRanks Smart Score
Company Description
ChronoScale
ChronoScale Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. The company is based in Dallas, Texas. ChronoScale Corporation operates as a subsidiary of Applied Digital Corporation.
23E1 Stock 12 Month Forecast
Average Price Target
€28.47
▲(77.51% Upside)